HomeEmerade™ Launch FAQs

Emerade™ Launch FAQs

October 20, 2020


Bausch Health, Canada, has announced that Emerade™ epinephrine auto-injectors are now available in pharmacies across Canada. Read their statement.

With Emerade, Canadians have an additional epinephrine auto-injector option. Below are answers to questions you may have about the product.  

Questions about the product

Q. What is Emerade?

Emerade is an epinephrine auto-injector used to treat anaphylaxis.

Q. What dosages are available in Canada?

There are two doses available with the Emerade device: 0.3 mg and 0.5 mg. In Canada, the 0.5 mg is a new dose option, please speak to your doctor to determine which dosage strength is best for you.

Q. What about a 0.15 mg dose?

Emerade does not have a 0.15 mg dosage in Canada at this time. 

Q. Is the dosing based on weight?

Weight is one consideration in the determination of a device. The decision on which device is best for you is based on clinical judgement. It’s important to speak to your doctor about the dosage strength and device that is best for you.

Q. Will the price be the same as the other devices in the market?

The price of the Emerade product may be lower than the cost of the other devices available in Canada.

Questions on access

Q. Where can I obtain an Emerade?

Emerade is available in pharmacies across Canada as of October 19, 2020. Please speak to your healthcare provider and check with your local pharmacy for additional availability details.

Q. Is a prescription required to obtain an Emerade?

Emerade is available as behind-the-counter medication and can be obtained without a prescription. However, different provinces and territories or insurance providers may require a prescription, depending on provincial or territorial requirements. You should contact your pharmacist or healthcare provider for information on how to obtain Emerade.

Q. Will prescriptions for EpiPen®, ALLERJECT®, and Emerade™ be interchangeable at the pharmacy?

This varies by province. In some cases, the pharmacist will need to call your healthcare professional to confirm that the switch is acceptable. 

Q. Is Emerade covered by public health insurance plans and private insurance companies?

Emerade is covered under the Ontario and Saskatchewan public health plans and most of the other Canadian provinces and territories are expected to list Emerade shortly. Emerade is also covered by many private insurance plans in Canada.

Q. How can I get a training device?

Training devices can be ordered from emerade.ca

Other questions

Q. Should I be using a new device during the COVID-19 pandemic?

The decision on which auto-injector to use should be discussed with your allergist and/or healthcare provider. During this time when there may be limited access to your primary healthcare provider, you can review the information provided on the Emerade website (emerade.ca) to better understand the features of the device and how to administer it.

More questions?

Visit emerade.ca for more information or call 1 800 361-4261. 

Tags: , ,